Alpha Cognition (ACOG) vs Veraxa Biotech (VRXA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Alpha Cognition (ACOG) has outperformed Veraxa Biotech (VRXA) over the past year, gaining 19.4% versus a loss of 88.0%. Alpha Cognition is the larger company by market cap ($196.9 million vs $178.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACOG | VRXA |
|---|---|---|
| Share price | $9.04 | $1.26 |
| Market cap | $196.87M | $178.17M |
| 1-day change | 0.00% | +15.60% |
| YTD return | +39.08% | -88.19% |
| 1-year return | +19.42% | -87.97% |
| EPS (TTM) | $-1.32 | $-0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.14 | $27.36 |
| 52-week low | $4.50 | $1.04 |
| Distance from 52-week high | -10.85% | -95.39% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +99.12% | — |
| Average volume | 125.72K | 263.43K |
| Shares outstanding | 21.78M | 141.41M |
| Employees | 71 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACOG has outperformed VRXA by 107.4 percentage points over the past year.
About Alpha Cognition
ACOG stock →Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Healthcare · Biotechnology · 71 employees
About Veraxa Biotech
VRXA stock →VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation.
Healthcare · Biotechnology
ACOG vs VRXA FAQ
Which is bigger, Alpha Cognition or Veraxa Biotech?
Alpha Cognition (ACOG) is larger, with a market capitalization of $196.87M compared with $178.17M for Veraxa Biotech (VRXA).
Which stock has performed better over the past year, ACOG or VRXA?
ACOG returned +19.42% over the past 12 months, compared with -87.97% for VRXA (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Cognition and Veraxa Biotech in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.